ES2046177T3 - Construccion de una proteina enlazante a igg para facilitar el tratamiento aguas abajo utilizando ingenieria de proteinas. - Google Patents
Construccion de una proteina enlazante a igg para facilitar el tratamiento aguas abajo utilizando ingenieria de proteinas.Info
- Publication number
- ES2046177T3 ES2046177T3 ES198686850416T ES86850416T ES2046177T3 ES 2046177 T3 ES2046177 T3 ES 2046177T3 ES 198686850416 T ES198686850416 T ES 198686850416T ES 86850416 T ES86850416 T ES 86850416T ES 2046177 T3 ES2046177 T3 ES 2046177T3
- Authority
- ES
- Spain
- Prior art keywords
- recombinant dna
- protein
- sequence
- fragment
- dna molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 238000010276 construction Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 7
- 102000053602 DNA Human genes 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 4
- 108020004705 Codon Proteins 0.000 abstract 2
- OQCPATDFWYYDDX-HGNGGELXSA-N Ala-Gln-His Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O OQCPATDFWYYDDX-HGNGGELXSA-N 0.000 abstract 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 108010088160 Staphylococcal Protein A Proteins 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 229940027941 immunoglobulin g Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000013600 plasmid vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA INVENCION SE REFIERE A: UN FRAGMENTO RECOMBINANTE DE ADN(Z) QUE CODIFICA UN DOMINIO DE UNION A INMUNOGLOBULINA G RELACIONADO CON LA PROTEINA A ESTAFILOCOCICA, QUE SE CARACTERIZA PORQUE LA METIONINA CODON DE DICHO FRAGMENTO HA SIDO REEMPLAZADA POR UN CODON DE OTRO RESTO DE AMINOACIDO LO QUE POSIBILITA LA EXPRESION DE UNA PROTEINA EXENTA DE METIONINA; UNA SECUENCIA DE ADN RECOMBINANTE QUE CONTIENE AL MENOS DOS DE TALES FRAGMENTOS; UNA SECUENCIA DE ADN RECOMBINANTE QUE CONTIENE DICHOS FRAGMENTOS PRECEDIDOS DE UNA SECUENCIA DE SEÑAL Y SEGUIDOS DE UNA SECUENCIA NUCLEOTIDA QUE CODIFICA LA SECUENCIA AMINO-ACIDO: ALA-GLU-HIS-ASP-GLU -ALA; UNA MOLECULA DE ADN RECOMBINANTE QUE CONTIENE DICHA SECUENCIA DE ADN RECOMBINANTE Y FUSIONADA EN 3'' A NIVEL DE ADN UN GEN DE PRODUCCION, QUE PUEDE EXPRESAR UNA PROTEINA; UN PROCESO PARA DESDOBLAR UNA PROTEINA FUNDIDA EXPRESADA EN UN SISTEMA BIOLOGICO POR DICHA MOLECULA RECOMBINANTE DE ADN; UN VECTOR PLASMIDICO QUE CONTIENE DICHA MOLECULA DE ADN RECOMBINANTE; Y UNA CELULA BACTERIANA QUE LLEVA LA MOLECULA DE ADN RECOMBINANTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8505922A SE8505922D0 (sv) | 1985-12-13 | 1985-12-13 | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2046177T3 true ES2046177T3 (es) | 1994-02-01 |
Family
ID=20362468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198686850416T Expired - Lifetime ES2046177T3 (es) | 1985-12-13 | 1986-12-02 | Construccion de una proteina enlazante a igg para facilitar el tratamiento aguas abajo utilizando ingenieria de proteinas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5143844A (es) |
EP (1) | EP0230869B1 (es) |
JP (1) | JPH0811069B2 (es) |
AT (1) | ATE80180T1 (es) |
AU (1) | AU600244B2 (es) |
CA (1) | CA1311430C (es) |
DE (1) | DE3686646T2 (es) |
DK (1) | DK600486A (es) |
ES (1) | ES2046177T3 (es) |
GR (1) | GR3006178T3 (es) |
SE (1) | SE8505922D0 (es) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK528285D0 (da) * | 1985-11-15 | 1985-11-15 | Novo Industri As | Peptider samt praeparater indeholdende disse |
SE8505921D0 (sv) * | 1985-12-13 | 1985-12-13 | Kabigen Ab | A method to export gene products to the growth medium of gram negative bacteria |
SE8601940D0 (sv) * | 1986-04-25 | 1986-04-25 | Kabigen Ab | Preparation of fused proteins, antibodies and processes therefor |
US5985599A (en) * | 1986-05-29 | 1999-11-16 | The Austin Research Institute | FC receptor for immunoglobulin |
ATE243754T1 (de) * | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
US5095096A (en) * | 1987-05-29 | 1992-03-10 | Sagami Chemical Research Center | Fused protein comprising lymphotoxin |
US5084398A (en) * | 1987-11-20 | 1992-01-28 | Creative Biomolecules | Selective removal of immune complexes |
US5243040A (en) * | 1987-11-20 | 1993-09-07 | Creative Biomolecules | DNA encoding a protein which enables selective removal of immune complexes |
JP2566325B2 (ja) * | 1987-11-20 | 1996-12-25 | クリエイティブ・バイオマリキュールズ・インコーポレーテッド | 免疫複合体の選択的除去 |
SE8800981A (sv) * | 1988-03-17 | 1988-10-14 | Lars Abrahamsen | A recombinant fusion protein, its use and a recombinant vector |
SE509359C2 (sv) * | 1989-08-01 | 1999-01-18 | Cemu Bioteknik Ab | Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel |
GB8927008D0 (en) * | 1989-11-29 | 1990-01-17 | Ciba Geigy | Novel process for the production of unfused protein in e.coli |
US5681814A (en) * | 1990-06-07 | 1997-10-28 | Genentech, Inc. | Formulated IGF-I Composition |
US5595887A (en) * | 1990-07-16 | 1997-01-21 | Bionebraska, Inc. | Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
US6077694A (en) * | 1990-09-21 | 2000-06-20 | The United States Of America As Represented By The Department Of Health And Human Services | Method for over-expression and rapid purification of biosynthetic proteins |
US5863783A (en) * | 1991-03-27 | 1999-01-26 | Gist-Brocades, N.V. | Cloning and expression of DNA molecules encoding arabinan-degrading enzymes of fungal origin |
US5736363A (en) * | 1991-07-29 | 1998-04-07 | British Bio-Technology Limited | IGF-II analogues |
US5989887A (en) * | 1992-11-25 | 1999-11-23 | Dsm N.V. | Cloning and expression of DNA molecules incoding arabinan-degrading enzymes of fungal origin |
SE9504019D0 (sv) * | 1995-11-13 | 1995-11-13 | Pharmacia Ab | Method for production of proteins |
US5917026A (en) * | 1996-02-05 | 1999-06-29 | Loewenadler; Bjoern | Fusion proteins of immunopotentiating activity |
US5962270A (en) * | 1996-02-06 | 1999-10-05 | Bionebraska, Inc. | Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs |
US5985830A (en) * | 1996-09-16 | 1999-11-16 | Dalhousie University | Use of IGF-I for the treatment of kidney disorders |
US6156728A (en) | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
US6593290B1 (en) | 1996-11-01 | 2003-07-15 | Genentech, Inc. | Treatment of inner ear hair cells |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
DK1141014T3 (da) | 1999-01-06 | 2005-04-11 | Genentech Inc | Insulinlignende vækstfaktor (IGF) i mutantvariant |
WO2000040612A1 (en) | 1999-01-06 | 2000-07-13 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variants |
DK1165119T3 (da) | 1999-04-08 | 2003-12-15 | Genentech Inc | Sammensætning baseret på modsat ladede polypeptider |
AU2001263215A1 (en) | 2000-05-16 | 2001-11-26 | Genentech Inc. | Method for treating cartilage disorders |
US20030157561A1 (en) * | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
SE0200943D0 (sv) | 2002-03-25 | 2002-03-25 | Amersham Biosciences Ab | Mutant protein |
US20050003548A1 (en) * | 2002-07-22 | 2005-01-06 | Nikolay Korokhov | Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
ATE536186T1 (de) | 2003-09-12 | 2011-12-15 | Tercica Inc | Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel |
EP1670822A2 (en) | 2003-10-03 | 2006-06-21 | Genentech, Inc. | Igf binding proteins |
WO2005097202A2 (en) | 2004-04-06 | 2005-10-20 | Affibody Ab | Use of serum albumin binding peptides conjugates for the preparation of a medicament |
WO2007056441A2 (en) | 2005-11-07 | 2007-05-18 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
EP1957540B1 (en) | 2005-12-02 | 2012-06-13 | Genentech, Inc. | Binding polypeptides and uses thereof |
JP2008048607A (ja) | 2006-08-22 | 2008-03-06 | Chisso Corp | Fc結合ドメインとカルシウム結合発光蛋白質との融合蛋白質、それをコードする遺伝子およびそれらの用途 |
GB2442118B (en) * | 2006-09-19 | 2011-08-17 | Chisso Corp | Process for production of recombinant proteins as a soluble form |
CA2666053C (en) | 2006-12-06 | 2011-03-29 | Repligen Corporation | Nucleic acids encoding recombinant protein a |
US8198043B2 (en) | 2006-12-08 | 2012-06-12 | General Electric Company | Two helix binders |
US8592555B2 (en) | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
SG195555A1 (en) * | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
CN102365361B (zh) | 2009-03-24 | 2015-09-02 | 株式会社钟化 | 对免疫球蛋白具有亲和性的蛋白质和免疫球蛋白结合性亲和配体 |
WO2010112193A1 (en) | 2009-04-02 | 2010-10-07 | Roche Glycart Ag | Multispecific antibodies comprising full length antibodies and single chain fab fragments |
SG179196A1 (en) | 2009-09-16 | 2012-04-27 | Genentech Inc | Coiled coil and/or tether containing protein complexes and uses thereof |
EP2544785B1 (en) | 2010-03-08 | 2015-09-30 | GE Healthcare Bio-Sciences AB | Immunoglobulin g fc region binding polypeptide |
SG184184A1 (en) | 2010-03-24 | 2012-10-30 | Kaneka Corp | Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
ES2617777T5 (es) | 2010-04-23 | 2022-10-13 | Hoffmann La Roche | Producción de proteínas heteromultiméricas |
EP2603525A1 (en) | 2010-08-13 | 2013-06-19 | F.Hoffmann-La Roche Ag | Antibodies to il-1beta and il-18, for treatment of disease |
JP5758004B2 (ja) | 2010-08-24 | 2015-08-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ジスルフィドによって安定化されたFv断片を含む二重特異性抗体 |
CN103269761B (zh) | 2010-12-20 | 2016-05-18 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
CN103269762B (zh) | 2010-12-20 | 2016-01-27 | 通用电气健康护理生物科学股份公司 | 亲和色谱基质 |
WO2012085111A1 (en) | 2010-12-23 | 2012-06-28 | F. Hoffmann-La Roche Ag | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery |
US10689447B2 (en) | 2011-02-04 | 2020-06-23 | Genentech, Inc. | Fc variants and methods for their production |
RU2013140685A (ru) | 2011-02-04 | 2015-03-10 | Дженентек, Инк. | ВАРИАНТЫ Fc, СПОСОБЫ ИХ ПОЛУЧЕНИЯ |
US9284354B2 (en) | 2011-03-25 | 2016-03-15 | Kaneka Corporation | Immunoglobulin-binding polypeptide |
SG10201604554WA (en) | 2011-06-08 | 2016-07-28 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
WO2013055958A1 (en) | 2011-10-11 | 2013-04-18 | Genentech, Inc. | Improved assembly of bispecific antibodies |
MX2014009565A (es) | 2012-02-10 | 2014-11-10 | Genentech Inc | Anticuerpos monocatenarios y otros heteromultimeros. |
JP6420756B2 (ja) * | 2012-03-28 | 2018-11-07 | ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ | アフィニティークロマトグラフィーマトリックス |
WO2014001325A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
BR112014032193A2 (pt) | 2012-06-27 | 2017-06-27 | Hoffmann La Roche | métodos de produção de anticorpos biespecíficos e de determinação de combinação, anticorpo biespecífico, formulação e uso de anticorpo biespecífico |
CN105377880B (zh) | 2013-07-10 | 2020-08-07 | 通用电气医疗集团生物工艺研发股份公司 | 突变的免疫球蛋白结合多肽 |
US10221211B2 (en) | 2013-09-27 | 2019-03-05 | Kaneka Corporation | Process for producing porous cellulose beads using alkali aqueous solution |
HUE063273T2 (hu) | 2014-05-06 | 2024-01-28 | Hoffmann La Roche | Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával |
US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
JP6721590B2 (ja) | 2014-12-03 | 2020-07-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 多重特異性抗体 |
JPWO2016121701A1 (ja) | 2015-01-26 | 2017-11-09 | 株式会社カネカ | 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス |
CN108064286A (zh) | 2015-01-26 | 2018-05-22 | 株式会社钟化 | 突变型免疫球蛋白κ链可变区结合性肽 |
JP6424101B2 (ja) * | 2015-01-30 | 2018-11-14 | Jnc株式会社 | Fc結合ドメインとカルシウム結合発光蛋白質との融合蛋白質、それをコードする遺伝子およびそれらの用途 |
JP6805831B2 (ja) | 2015-02-05 | 2020-12-23 | 三菱ケミカル株式会社 | 免疫グロブリンに親和性を有するタンパク質、およびそれを用いたアフィニティ分離剤、液体クロマトグラフィー用カラム |
WO2017195638A1 (ja) | 2016-05-09 | 2017-11-16 | 株式会社カネカ | 抗体またはκ鎖可変領域含有抗体断片の精製方法 |
CN109071613A (zh) | 2016-05-11 | 2018-12-21 | 通用电气医疗集团生物工艺研发股份公司 | 分离基质 |
US11708390B2 (en) | 2016-05-11 | 2023-07-25 | Cytiva Bioprocess R&D Ab | Method of storing a separation matrix |
US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
WO2017194593A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
WO2019030156A1 (en) | 2017-08-07 | 2019-02-14 | Repligen Corporation | FC BINDING PROTEINS WITH CYSTEINE IN THE C-TERMINAL HELICAL REGION |
GB202018588D0 (en) | 2020-11-26 | 2021-01-13 | Cytiva Bioprocess R & D Ab | Separation matrix |
GB202113626D0 (en) | 2021-09-24 | 2021-11-10 | Cytiva Bioprocess R & D Ab | FC binding polypeptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769326A (en) * | 1980-02-29 | 1988-09-06 | The Regents Of The University Of California | Expression linkers |
SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
-
1985
- 1985-12-13 SE SE8505922A patent/SE8505922D0/xx unknown
-
1986
- 1986-12-02 EP EP86850416A patent/EP0230869B1/en not_active Expired
- 1986-12-02 AT AT86850416T patent/ATE80180T1/de not_active IP Right Cessation
- 1986-12-02 DE DE8686850416T patent/DE3686646T2/de not_active Expired - Fee Related
- 1986-12-02 ES ES198686850416T patent/ES2046177T3/es not_active Expired - Lifetime
- 1986-12-09 AU AU66331/86A patent/AU600244B2/en not_active Ceased
- 1986-12-12 JP JP61296509A patent/JPH0811069B2/ja not_active Expired - Lifetime
- 1986-12-12 CA CA000525167A patent/CA1311430C/en not_active Expired - Fee Related
- 1986-12-12 DK DK600486A patent/DK600486A/da not_active Application Discontinuation
-
1990
- 1990-10-09 US US07/594,564 patent/US5143844A/en not_active Expired - Lifetime
-
1992
- 1992-11-05 GR GR920402499T patent/GR3006178T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3006178T3 (es) | 1993-06-21 |
DE3686646D1 (de) | 1992-10-08 |
JPH0811069B2 (ja) | 1996-02-07 |
DE3686646T2 (de) | 1993-04-08 |
EP0230869A3 (en) | 1988-08-03 |
ATE80180T1 (de) | 1992-09-15 |
SE8505922D0 (sv) | 1985-12-13 |
JPS62190087A (ja) | 1987-08-20 |
CA1311430C (en) | 1992-12-15 |
US5143844A (en) | 1992-09-01 |
AU600244B2 (en) | 1990-08-09 |
EP0230869A2 (en) | 1987-08-05 |
EP0230869B1 (en) | 1992-09-02 |
AU6633186A (en) | 1987-06-18 |
DK600486A (da) | 1987-06-14 |
DK600486D0 (da) | 1986-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2046177T3 (es) | Construccion de una proteina enlazante a igg para facilitar el tratamiento aguas abajo utilizando ingenieria de proteinas. | |
IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
Kodaira et al. | The dnaX gene encodes the DNA polymerase III holoenzyme τ subunit, precursor of the γ subunit, the dnaZ gene product | |
IL57491A (en) | Recombinant dna,methods for the production thereof and proteins or polypeptides produced thereby | |
ZA822855B (en) | Bacillus cloning vectors,recombinant dna molecules,bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby | |
EP1757689A3 (en) | Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods | |
EP0048970A3 (en) | Polypeptides, process for their microbial production, intermediates therefor and compositions containing them | |
NZ510367A (en) | Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector | |
LV5288A3 (lv) | Nukleinskabes fragments kurs kode cilveka proapolipoproteinu A-1 | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
ATE426024T1 (de) | C-c chemokin rezeptor 3: ckr-3 oder eos-l2 | |
NO910797L (no) | Dna-fragment som koder for et polypeptid med nitrilhydratase-aktivitet, en transformant inneholdende genet og en fremgangsmaate for fremstilling av amider ved bruk av transformanten. | |
AR023482A1 (es) | Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos | |
Johnson et al. | Identification of a plastid-specific ribosomal protein in the 30 S subunit of chloroplast ribosomes and isolation of the cDNA clone encoding its cytoplasmic precursor. | |
Sung et al. | Renaturation of DNA catalysed by yeast DNA repair and recombination protein RAD1O | |
Saraste et al. | A gene in Paracoccus for subunit III of cytochrome oxidase | |
GR3023593T3 (en) | Protein structure of the plant toxin gelonin | |
Sarvas et al. | A precursor form of the penicillinase from Bacillus licheniformis | |
DK0805204T3 (da) | Bitestikel - specifikt receptorprotein og anvendelse heraf | |
ATE46188T1 (de) | Positionsspezifische proteolyse mittels renin. | |
Taylor et al. | Similarities in the heavy and light chains of tetanus toxin suggested by their amino acid compositions | |
ES2111537T3 (es) | Inhibidor de la ribonucleasa de placenta humana recombinante y metodo de produccion. | |
WO1998025957A3 (en) | Human prt1-like subunit protein (hprt1) and human eif4g-like protein (p97) genes | |
IL78278A0 (en) | Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules | |
AU2002365538A1 (en) | Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 230869 Country of ref document: ES |